Adam E. Fine

Solo GP · New York, NY

Verified active in the last 12 months

Adam E. Fine is a solo GP based in New York, NY focused on Healthcare, Biotech & Pharma, investing at seed, series a stage. Adam E. Fine's most recent fund with a disclosed size, Windham Life Sciences Partners IV, L.P., filed a $150M offering with the SEC in Nov 2025. Estimated typical check: $1.5M–$4.5M. Adam E. Fine has dated investing activity in the last 12 months (latest Nov 2025).

Why Adam E. Fine is listed

Named as the only individual (Managing Member of General Partner) on the Form D for Windham Life Sciences Partners IV, L.P., a $150M venture fund (Nov 2025). Also a non-executive director at 2 startups that filed Form D.

Source: SEC Form D: Windham Life Sciences Partners IV, L.P. (Nov 13, 2025) · 2 more sources

Is this you? Remove or correct this profile.

Stages: Seed, Series A
Typical check (est.): $1.5M–$4.5M
Latest fund: $150M · Nov 2025
Latest dated activity: Nov 2025

Is Adam E. Fine a fit for you?

See your fit score and the reason, contact details, and any warm path from your network.

Start 3-day trial to see contacts

What does Adam E. Fine invest in?

HealthcareBiotech & Pharma

What has Adam E. Fine invested in recently?

RxWare
Board seat on the company's SEC filing (not by itself proof of an investment) · DE
May 2024
Valera Health
Board seat on the company's SEC filing (not by itself proof of an investment) · NY
Apr 2024
Windham Life Sciences Partners IV, L.P.
Invested through a fund
Nov 2023

Funds and deal vehicles Adam E. Fine filed with the SEC

Windham Life Sciences Partners IV, L.P.
Fund · $150M offering
Nov 2025

Sources

SEC Form D: Windham Life Sciences Partners IV, L.P.Nov 13, 2025
SEC Form D (board seat): Valera HealthApr 9, 2024
SEC Form D (board seat): RxWareMay 7, 2024

Data refreshed from public sources Oct 15, 2026. Is this you? Remove or correct this profile.